Devajit Mohajan and Haradhan Kumar Mohajan, “Alpha-Glucosidase Inhibitors (AGIs): A New Class of Oral Medication for Treatment of Type 2 Diabetes Patients”, JIMR, vol. 3, no. 4, pp. 1–6, Nov. 2024.